Oxalate as a potent promoter of kidney stone formation

被引:21
作者
Chen, Tao [1 ,2 ,3 ]
Qian, Biao [2 ,3 ]
Zou, Junrong [2 ,3 ]
Luo, Peiyue [1 ,2 ,3 ]
Zou, Jun [1 ,2 ,3 ]
Li, Wei [1 ,2 ,3 ]
Chen, Qi [1 ,2 ,3 ]
Zheng, Liying [4 ]
机构
[1] Gannan Med Univ, Clin Coll 1, Ganzhou, Jiangxi, Peoples R China
[2] Gannan Med Univ, Affiliated Hosp 1, Dept Urol, Ganzhou, Jiangxi, Peoples R China
[3] Key Lab Urol & Androl Ganzhou, Ganzhou, Jiangxi, Peoples R China
[4] Ganna Med Univ, Affiliated Hosp 1, Dept Grad, Ganzhou, Jiangxi, Peoples R China
关键词
oxalate; kidney stones; gut microbiome; kindey; hyperoxaluria; OXALOBACTER-FORMIGENES COLONIZATION; URINARY OXALATE; PROXIMAL TUBULE; ANION-EXCHANGER; N-GLYCOSYLATION; GUT MICROBIOME; STAS DOMAIN; MOUSE MODEL; TRANSPORT; HYPEROXALURIA;
D O I
10.3389/fmed.2023.1159616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Kidney stones are among the most prevalent urological diseases, with a high incidence and recurrence rate. Treating kidney stones has been greatly improved by the development of various minimally invasive techniques. Currently, stone treatment is relatively mature. However, most current treatment methods are limited to stones and cannot effectively reduce their incidence and recurrence. Therefore, preventing disease occurrence, development, and recurrence after treatment, has become an urgent issue. The etiology and pathogenesis of stone formation are key factors in resolving this issue. More than 80% of kidney stones are calcium oxalate stones. Several studies have studied the formation mechanism of stones from the metabolism of urinary calcium, but there are few studies on oxalate, which plays an equally important role in stone formation. Oxalate and calcium play equally important roles in calcium oxalate stones, whereas the metabolism and excretion disorders of oxalate play a crucial role in their occurrence. Therefore, starting from the relationship between renal calculi and oxalate metabolism, this work reviews the occurrence of renal calculi, oxalate absorption, metabolism, and excretion mechanisms, focusing on the key role of SLC26A6 in oxalate excretion and the regulatory mechanism of SLC26A6 in oxalate transport. This review provides some new clues for the mechanism of kidney stones from the perspective of oxalate to improve the understanding of the role of oxalate in the formation of kidney stones and to provide suggestions for reducing the incidence and recurrence rate of kidney stones.
引用
收藏
页数:13
相关论文
共 121 条
[71]   Short-Chain Fatty Acids Reduced Renal Calcium Oxalate Stones by Regulating the Expression of Intestinal Oxalate Transporter SLC26A6 [J].
Liu, Yu ;
Jin, Xi ;
Ma, Yucheng ;
Jiang, Zhongyu ;
Wei, Zhitao ;
Xiang, Liyuan ;
Sun, Qun ;
Qi, Shigian ;
Wang, Kunjie ;
Li, Hong .
MSYSTEMS, 2021, 6 (06)
[72]   The relationship between gut microbiota and short chain fatty acids in the renal calcium oxalate stones disease [J].
Liu, Yu ;
Jin, Xi ;
Hong, Hyokyoung G. ;
Xiang, Liyuan ;
Jiang, Qingyao ;
Ma, Yucheng ;
Chen, Zude ;
Cheng, Liang ;
Jian, Zhongyu ;
Wei, Zhitao ;
Ai, Jianzhong ;
Qi, Shiqian ;
Sun, Qun ;
Li, Hong ;
Li, Yi ;
Wang, Kunjie .
FASEB JOURNAL, 2020, 34 (08) :11200-11214
[73]   Isoforms of SLC26A6 mediate anion transport and have functional PDZ interaction domains [J].
Lohi, H ;
Lamprecht, G ;
Markovich, D ;
Heil, A ;
Kujala, M ;
Seidler, U ;
Kere, J .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 284 (03) :C769-C779
[74]   In Silico Screening and Molecular Dynamic Study of Nonsynonymous Single Nucleotide Polymorphisms Associated with Kidney Stones in the SLC26A6 Gene [J].
Lu, Xiuli ;
Sun, Deliang ;
Xu, Bo ;
Pan, Jichuan ;
Wei, Yanhong ;
Mao, Xu ;
Yu, Daojun ;
Liu, Hongsheng ;
Gao, Bing .
JOURNAL OF UROLOGY, 2016, 196 (01) :118-123
[75]   Oxalate in renal stone disease: the terminal metabolite that just won't go away [J].
Marengo, Susan R. ;
Romani, Andrea M. P. .
NATURE CLINICAL PRACTICE NEPHROLOGY, 2008, 4 (07) :368-377
[76]   Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis [J].
Miller, Aaron W. ;
Choy, David ;
Penniston, Kristina L. ;
Lange, Dirk .
KIDNEY INTERNATIONAL, 2019, 96 (01) :180-188
[77]   A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria [J].
Milliner, Dawn ;
Hoppe, Bernd ;
Groothoff, Jaap .
UROLITHIASIS, 2018, 46 (04) :313-323
[78]   Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation [J].
Mittal, RD ;
Kumar, R ;
Mittal, B ;
Prasad, R ;
Bhandari, M .
MEDICAL PRINCIPLES AND PRACTICE, 2003, 12 (04) :208-213
[79]   Phenotypic and Functional Analysis of Human SLC26A6 Variants in Patients With Familial Hyperoxaluria and Calcium Oxalate Nephrolithiasis [J].
Monico, Carla G. ;
Weinstein, Adam ;
Jiang, Zhirong ;
Rohlinger, Audrey L. ;
Cogal, Andrea G. ;
Bjornson, Beth B. ;
Olson, Julie B. ;
Bergstralh, Eric J. ;
Milliner, Dawn S. ;
Aronson, Peter S. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 52 (06) :1096-1103
[80]   Steatorrhea and Hyperoxaluria in Severely Obese Patients Before and After Roux-en-Y Gastric Bypass [J].
Moreland, Amber M. ;
Santa Ana, Carol A. ;
Asplin, John R. ;
Kuhn, Joseph A. ;
Holmes, Ross P. ;
Cole, Jason A. ;
Odstrcil, Elizabeth A. ;
Van Dinter, Thomas G., Jr. ;
Martinez, Juan G. ;
Fordtran, John S. .
GASTROENTEROLOGY, 2017, 152 (05) :1055-+